Business

AstraZeneca Merger Talks with Bristol Myers Squibb

Updated 2026-08-03 08:10 UTC 1 source Negative

AstraZeneca's shares dropped 7% after reports of ongoing merger talks with Bristol Myers Squibb. The companies have discussed a potential $400 billion deal over several months, according to the Financial Times.

Coverage timeline — 1 article

CNBC

AstraZeneca shares drop 7% after report on $400 billion merger talks with Bristol Myers Squibb

The companies have discussed a potential merger over several months, the Financial Times reported on Sunday.

2026-08-03 07:52 UTC